Abstract
PDK1 is pivotal in the development and progression of several cancers. A 3D pharmacophore was developed for pyrazole derivatives displaying anti-proliferative activity and PDK1 inhibition. The pharmacophore was utilized in the design of benzimidazole analogs. Our preliminary results indicate the pharmacophore should be useful in designing PDK1 inhibitors and anti-proliferative agents. © 2008 Bentham Science Publishers Ltd.
Cite
CITATION STYLE
Winfield, L., Smith, D., Halemano, K., & Leggett, C. (2008). A Preliminary Assessment of the Structure-Activity Relationship of Benzimidazole-Based Anti-Proliferative Agents. Letters in Drug Design & Discovery, 5(6), 369–376. https://doi.org/10.2174/157018008785777324
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.